Brown Advisory’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.2M Buy
241,770
+14,358
+6% +$2.06M 0.05% 255
2025
Q4
$32.4M Buy
+227,412
New +$30.5M 0.05% 258
2021
Q2
Sell
-21,103
Closed -$4.33M 1103
2021
Q1
$4.33M Buy
+21,103
New +$4.46M 0.01% 489
2018
Q4
Sell
-1,664
Closed -$471K 1292
2018
Q3
$471K Sell
1,664
-121
-7% -$35.4K ﹤0.01% 1007
2018
Q2
$524K Buy
1,785
+44
+3% +$12K ﹤0.01% 964
2018
Q1
$439K Sell
1,741
-132
-7% -$31K ﹤0.01% 865
2017
Q4
$404K Buy
1,873
+70
+4% +$14.2K ﹤0.01% 946
2017
Q3
$335K Buy
+1,803
New +$314K ﹤0.01% 982

Other funds holding ICUI

Brown Advisory's ICUI Position: Q1 2026 in Review

Brown Advisory increased its ICU Medical (ICUI) stake by 6.3% in Q1 2026, buying an estimated $2.06M and bringing the position to 241,770 shares worth $31.2M. The position accounts for 0.05% of the portfolio, ranked #255.

Brown Advisory first reported a position in ICUI in Q3 2017 and has held it in 8 quarters since. The position peaked at $32.4M in Q4 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • Brown Advisory held 241,770 shares of ICU Medical worth $31.2M as of Q1 2026.
  • Brown Advisory bought 14,358 ICU Medical shares in Q1 2026, an estimated $2.06M.
  • ICU Medical made up 0.05% of Brown Advisory's portfolio in Q1 2026, its #255 holding.
  • Brown Advisory first reported a position in ICU Medical in Q3 2017 and has held it in 8 quarters since.
  • Brown Advisory's ICU Medical position peaked at $32.4M in Q4 2025.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.